News

Mayo Clinic scientists have developed an immunotherapy strategy that utilizes CAR-MSCs. The approach shows potential in targeting inflammatory disease sites more precisely and improving immunosuppression and healing outcomes.

Engineering a virus that infects a frog-killing fungus could be the answer to controlling the spread of disease and saving the amphibians.

In recent years, scientists and companies have started using microbes to grow sustainable textiles or to make dyes for industry – but this is the first time bacteria have been engineered to produce a material and its own pigment simultaneously.

Researchers have found a different and promising way to remove the noxious amyloid plaques in Alzheimer's disease: by directly mobilizing immune cells to consume them.

In a paper published this week in APL Materials, by AIP Publishing, researchers created a hydrogel that is easier to synthesize, contains natural antibiotic properties, and promotes cell growth.

Infant gut microbiomes oscillate with a circadian rhythm, even when they are cultivated outside of the body. Researchers report that the rhythm is detectable as early as 2 weeks after birth but becomes more pronounced with age.

RNA decay is a crucial mechanism for controlling gene expression and a new study shows that bacterial RNA decays faster than previously thought.

The mRNA vaccines developed through the federal government's "Operation Warp Speed" program were a massive innovation; however, annually updating those boosters for specific SARS-CoV-2 variants is inefficient for scientists and patients.

Researchers have discovered that the more urbanized the person, the less cellulose-degrading bacteria found in their gut.

A synthetic material could lower the difficulty and barrier to entry for researchers studying how microorganisms interact with the gastrointestinal system and potentially improve labs' ability to screen drugs that impact gut health.